Showing results (331-340 of 339) with videos related to
Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 339 results.
BMC Genomics|February 10, 2026
Generation of quartet reference materials for preimplantation genetic testing for structural rearrangementsNan Sun, Wenxin Zhang, Dandan Yu, et al.Cancer Letters|July 19, 2025
Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancerJiahua He, Weihao Li, Song Wang, et al.Clinical and Translational Medicine|August 27, 2025
β-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1Jin Lan, Weili Zhang, Kaixuan Zeng, et al.Communications Biology|December 27, 2022
A standalone incompatible insect technique enables mosquito suppression in the urban subtropicsQin Zeng, Lingzhi She, Hao Yuan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03Xinan Sheng, Haige Chen, Bin Hu, et al.The Oncologist|August 15, 2019
An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and ImmunotherapiesJingyu Cao, Lijuan Chen, Heng Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2021
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, et al.Journal of Medicinal Chemistry|January 5, 2024
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor ModelsMichael Berlin, Jennifer Cantley, Mark Bookbinder, et al.Nature Communications|July 23, 2022
Landscape of somatic alterations in large-scale solid tumors from an Asian populationLiqun Wu, Herui Yao, Hui Chen, et al.Pageof 34